Skip to content

Screener

Eligibility screening

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe System…

Sponsored by AbbVieStudy detailsClinicalTrials.gov

132 US sites in AR, AZ, CA, CO +24

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.